Evidence map›Paper›PMID 19059880›Full record

ArticleBlood2009

Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression.

Stephen M Jackson, Natessa Harp, Darshna Patel, Jordan Wulf, Erich D Spaeth, Uzoamaka K Dike, Judith A James, J Donald Capra

Abstract read
In one paragraph

Article in Blood, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Atypical and non-classical CD45RBNature communications · 2024
    Article
  3. Article
  4. A synthetic human 3DiScience · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Glycosylation in health and disease.Nature reviews. Nephrology · 2019
    Review
  9. Article
  10. Review
  11. Chronic airway inflammation provides a unique environment for B cell activation and antibody production.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2017
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stephen M JacksonMolecular Immunogenetics Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Natessa Harp
Darshna Patel
Jordan Wulf
Erich D Spaeth
Uzoamaka K Dike
Judith A James
J Donald Capra

Funding

THE EFFECTS OF ERK PATHWAY INHIBITION ON DNA METHYLATION IN SLEP20RR015577 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI CENTOLA, MICHAEL B · 2000 to 2009
$21.5M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
IMMUNOGLOBULIN V REGION STRUCTURES: GENETIC IMPLICATIONR01AI012127 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI CAPRA, J DONALD · 1985 to 2003
$1.2M
IMMUNOGLOBULIN V REGION STRUCTURES;GENETIC IMPLICATIONSR37AI012127 · NIAID · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI CAPRA, J DONALD · 1987 to 1997
–
NCRR NIH HHS P20 RR015577NCRR NIH HHS RR15577NIAID NIH HHS AI 12127NIAMS NIH HHS P30 AR053483
6 · The paper itself

Abstract

We previously reported that RO(+) expression correlated with increased mutation, activation, and selection among human germinal center (GC) B cells. Here, we subdivided human tonsillar B cells, including IgD(-)CD38(+) GC B cells, into different fractions based on RB expression. Although each subset contained RB(+) cells, when used as an intrasubset marker, differential RB expression effectively discriminated between phenotypically distinct cells. For example, RB(+) GC B cells were enriched for activated cells with lower AID expression. RB inversely correlated with mutation frequency, demonstrating a key difference between RB- and RO-expressing GC B cells. Reduced RB expression during the transition from pre-GC (IgM(+)IgD(+)CD38(+)CD27(-)) to GCB cells was followed by a dramatic increase during the GC-to-plasmablast (IgD(-)CD38(++)CD27(+)) and memory (IgD(-)CD38(-)CD27(+)) transition. Interestingly, RB(+) GC B cells showed increased signs of terminal differentiation toward CD27(+) post-GC early plasmablast (increased CD38 and RO) or early memory (decreased CD38 and RO) B cells. We propose that as in T cells, differential RB expression directly correlates with development- and function-based transitions in tonsillar B cells. Application of this RB:RO system should advance our understanding of normal B-cell development and facilitate the isolation of more discrete B-cell populations with potentially different propensities in disease pathogenesis.

Indexed as

ADP-ribosyl Cyclase 1BiomarkersB-LymphocytesCell MembraneCell SeparationFlow CytometryGerminal CenterHumansImmunity, InnateImmunoglobulin DImmunoglobulin Variable RegionImmunologic MemoryLeukocyte Common AntigensLymphocyte ActivationLymphopoiesisMutationADP-ribosyl Cyclase 1BiomarkersImmunoglobulin DImmunoglobulin Variable RegionLeukocyte Common AntigensProtein IsoformsTumor Necrosis Factor Receptor Superfamily, Member 7

Identifiers

PMID19059880
PMCPMC2673126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.